
Rx Rundown: Sanofi, Roche, AstraZeneca and more
Deals: Sanofi bought U.K.-based Vicebio for $1.6 billion. Novartis agreed to pay up to $1 billion to Matchpoint Therapeutics to develop oral drugs for several inflammatory diseases. Pacira BioSciences announced a strategic collaboration with Johnson & …